IVF Hartmann Holding AG
SIX:VBSN
Intrinsic Value
IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. [ Read More ]
The intrinsic value of one VBSN stock under the Base Case scenario is 121.26 CHF. Compared to the current market price of 143 CHF, IVF Hartmann Holding AG is Overvalued by 15%.
Valuation Backtest
IVF Hartmann Holding AG
Run backtest to discover the historical profit from buying and selling VBSN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
IVF Hartmann Holding AG
Current Assets | 131.5m |
Cash & Short-Term Investments | 39.8m |
Receivables | 65m |
Other Current Assets | 26.8m |
Non-Current Assets | 48.8m |
PP&E | 45.1m |
Intangibles | 3.7m |
Current Liabilities | 32.4m |
Accounts Payable | 4.3m |
Accrued Liabilities | 12.5m |
Other Current Liabilities | 15.6m |
Non-Current Liabilities | 4.2m |
Long-Term Debt | 504k |
Other Non-Current Liabilities | 3.7m |
Earnings Waterfall
IVF Hartmann Holding AG
Revenue
|
150.6m
CHF
|
Cost of Revenue
|
-70m
CHF
|
Gross Profit
|
80.6m
CHF
|
Operating Expenses
|
-67.3m
CHF
|
Operating Income
|
13.3m
CHF
|
Other Expenses
|
-2.1m
CHF
|
Net Income
|
11.2m
CHF
|
Free Cash Flow Analysis
IVF Hartmann Holding AG
VBSN Profitability Score
Profitability Due Diligence
IVF Hartmann Holding AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
IVF Hartmann Holding AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
VBSN Solvency Score
Solvency Due Diligence
IVF Hartmann Holding AG's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
IVF Hartmann Holding AG's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VBSN Price Targets Summary
IVF Hartmann Holding AG
Shareholder Return
VBSN Price
IVF Hartmann Holding AG
Average Annual Return | -1.65% |
Standard Deviation of Annual Returns | 23.53% |
Max Drawdown | -45% |
Market Capitalization | 343.2m CHF |
Shares Outstanding | 2 388 245 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. The company is headquartered in Neuhausen Am Rheinfall, Schaffhausen and currently employs 340 full-time employees. The company went IPO on 2012-07-16. The firm's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The firm also offers consulting services, on-site or in classrooms, related to the usage of its products. The firm's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. The company also operates subsidiaries located in Switzerland.
Contact
IPO
Employees
Officers
The intrinsic value of one VBSN stock under the Base Case scenario is 121.26 CHF.
Compared to the current market price of 143 CHF, IVF Hartmann Holding AG is Overvalued by 15%.